Investors Sue Abbott Over $1.5B Depakote Settlement Tab
By Roxanne Palmer · November 30, 2011, 6:06 PM EST
Two Abbott Laboratories Inc. shareholders sued the company's board in Illinois federal court Tuesday, claiming executives negligently allowed Abbott to promote improper off-label uses for its anti-seizure medication Depakote, forcing the...
To view the full article, register now.